Dino Kocijancic

Title: The Innovative Contributions of Dino Kocijancic

Introduction

Dino Kocijancic is a notable inventor based in Braunschweig, Germany. He has made significant contributions to the field of immunology through his innovative research and patents. His work focuses on developing immunogenic compositions that have potential applications in cancer treatment.

Latest Patents

Dino Kocijancic holds a patent for an immunogenic composition that includes a mutated strain with specific mutations in flagellin II genes, such as the fliF gene. This invention also encompasses additional mutations in genes like aroA, IpxR, pagP, pagL, ydiV, and optionally eptA and arnT. The patent outlines a method for producing outer membrane vesicles (OMVs) from this strain, which can be used as a transport moiety or as part of an immunogenic composition, such as a vaccine or immunotherapy platform, particularly for the therapeutic treatment of cancer.

Career Highlights

Dino Kocijancic is affiliated with Helmholtz-Zentrum für Infektionsforschung GmbH, where he conducts his research. His work has led to advancements in the understanding of immunogenic compositions and their applications in medical therapies.

Collaborations

Dino collaborates with esteemed colleagues, including Marc Erhardt and Sebastian Felgner, to further enhance the impact of his research in the field of immunology.

Conclusion

Dino Kocijancic's innovative work in developing immunogenic compositions showcases his commitment to advancing medical science. His contributions have the potential to significantly impact cancer treatment and immunotherapy.